Guillory v. United States

59 Fed. Cl. 121, 2003 U.S. Claims LEXIS 251, 2003 WL 23095269
United States Court of Federal Claims·Decided August 28, 2003·No. No. 99-651V·Published·Cited by 230 cases

Opinion

[122] OPINION

HEWITT, Judge.

Petitioner Donna S. Guillory seeks review of the special master’s denial of compensation under the National Vaccine Injury Compensation Program (Vaccine Act). 42 U.S.C. §§ 300aa-10 to 300aa-34 (2000). In an unpublished decision filed on March 28, 2003, the special master concluded that petitioner failed to present a prima facie case that Hepatitis B vaccinations caused her neurological defects. Guillory v. Sec’y of Health & Human Servs.,1 No. 99-651 V, Slip. Op. at 1, 6 (Fed.Cl.Spec.Mstr. Mar. 28, 2003) (Slip. Op.). Petitioner filed this appeal timely on April 23, 2003. Petitioner’s Request for Review of Decision of Special Master (Mot.) at 1. For the reasons set forth below, petitioner’s motion for review is DENIED.

I. Background2

In 1992, Ms. Guillory worked at St. Jude Medical Center (Medical Center) in Kenner, Louisiana, as an eleetroneurodiagnostic technologist. Slip. Op. at 2. Ms. Guillory participated in the Medical Center’s campaign to immunize employees against Hepatitis-B and received her first Hepatitis-B vaccination on July 10, 1992. Id. at 2-3. Following this vaccination Ms. Guillory experienced chills, sweats, and site tenderness that ended within 48 hours. Id. at 3.

Ms. Guillory received her second Hepatitis-B vaccination on August 10, 1992. Slip. Op. at 3. She again experienced chills, sweats, and site tenderness for a few days. Id. On August 14, 1992, Ms. Guillory underwent elective, outpatient surgery for removal of a “left wrist dorsal ganglion cyst.” Id. Ms. Guillory noted numbness in her face after awakening from a nap on August 15, 1992. Id. She was advised by emergency room personnel that she “probably slept wrong.” Id. She felt “okay” for a couple of days but, on August 17,1992, she “really wasn’t feeling well.” Id. According to Dr. Terence D’Souza (Dr. Souza), a neurologist with whom she worked, Ms. Guillory appeared “unsteady” and walked with a “slightly broad-based gait.” Id.

Dr. Souza performed a brief, informal neurological examination of Ms. Guillory to rule out a brain tumor and also recommended a magnetic resonance imaging (MRI) study to rule out a stroke. Slip. Op. at 3. The MRI was normal but as a precaution Dr. Souza recommended that Ms. Guillory discontinue birth control pill use and institute aspirin therapy. Id.

Within a week, most of Ms. Guillory’s symptoms subsided but she continued to have intermittent tingling around the mouth for several months. Slip. Op. at 3. She did not seek medical attention for these symptoms. Id.

On January 15,1993, Ms. Guillory received her third Hepatitis B vaccination. Slip. Op. at 3. While driving home she experienced swelling of the feet. Id. at 3-4. Later that evening she developed a rash that covered her abdomen, chest, and neck. Id. at 4. Ms. Guillory contacted the nurse who administered the vaccination and was advised to take Benadryl. Id. On January 16, 1993, Ms. Guillory experienced flu-like symptoms, including chills and sweats. Id.

On May 27, 1993, Ms. Guillory awoke with pressure in her head and pain in her spine that radiated into both of her legs. Slip. Op. at 4. She fell when she attempted to stand. Id. Ms. Guillory consulted an internist, Dr. L. Gabriel Uribe (Dr. Uribe), who referred her to a neurologist, Dr. Michael Wilensky (Dr. Wilensky). Id. at 2, 4. The record indicated that Dr. Wilensky performed a battery of neurological tests in May and prescribed Klo-nopin for dizziness. Id.

On May 31, 1993, Dr. Wilensky evaluated Ms. Guillory and determined that she was suffering from weakness in her legs. Slip. Op. at 4. Dr. Wilensky observed that her tandem gait was poor. Id. Ms. Guillory tested positive for peripheral ataxia. Id. Dr. Wilensky diagnosed “dizziness” and pre[123] scribed Tegretol to complement Klonopin. Id.

On June 7,1993, Dr. Wilensky hospitalized Ms. Guillory for additional testing. Slip. Op. at 4. Dr. Wilensky initially diagnosed Ms. Guillory with “acute transverse myelitis” and began steroid therapy. Id. Ms. Guillory’s motor weakness improved but she developed “more cerebellar signs” and “increased neuralgic pain in the posterior thoracic wall bilaterally.” Id. at 5. Dr. Wilensky proceeded to review additional aspects of Ms. Guillory’s medical history and this prompted him to question whether Ms. Guillory’s “present condition” was “an encephalomyelitis (post-vaccination type).” Id.

Dr. Wilensky discharged Ms. Guillory from the hospital on June 11,1993. Slip. Op. at 5. He concluded that Ms. Guillory had “transverse myelitis with additional cerebellar signs suggestive of encephalomyelitis.” Id. Dr. Wilensky informed Ms. Guillory that “there may be a relationship” between the Hepatitis B vaccination and her “neurologic condition” based upon “the close history of the hepatitis vaccination.” Id.

Dr. Wilensky continued to monitor Ms. Guillory’s neurological condition. Id. In August 1993, he stated to her that her neurological condition was associated with her Hepatitis B vaccinations and explained to her that his conclusion was arrived at by “basically a process of ehmination.” Id.

The special master held a hearing at which Ms. Guillory presented four witnesses dining her case-in-chief. Slip. Op. at 2. Ms. Guillory and Dr. Souza provided fact testimony and Dr. Wilensky provided both fact and expert testimony. Id. Dr. Leon Weisberg (Dr. Weisberg), a neurologist who examined Ms. Guillory as part of a Louisiana Workers’ Compensation Board proceeding, provided expert testimony. Id. Respondent presented one witness, Dr. Kottil Rammohan (Dr. Ram-mohan), for rebuttal expert testimony. Following the hearing, the special master issued the unpublished Memorandum Decision On Entitlement denying Ms. Guillory’s request for compensation under the Vaccine Act. Id. at 1.

II. Discussion

A. Standard of Review

When deciding a motion for review of a special master’s decision, the court may

(A) uphold the findings of fact and conclusions of law of the special master and sustain the special master’s decision,
(B) set aside any findings of fact or conclusion of law of the special master found to be arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with law and issue its own findings of fact and conclusions of law, or
(C) remand the petition to the special master for further action in accordance with the court’s direction.

Free access — add to your briefcase to read the full text and ask questions with AI

Guillory v. United States, 59 Fed. Cl. 121, 2003 U.S. Claims LEXIS 251, 2003 WL 23095269 (uscfc 2003).

59 Fed. Cl. 121 (Guillory v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related